Shifting B.C. biotech sector regroups
Business in Vancouver
June 6-12, 2006 

Cardiome shares dive after FDA refusal
Vancouver Sun
June 1, 2006

Anormed founder steps down as part of corporate transition
Business in Vancouver
May 30 - June 5, 2006

B.C. high tech loses an edge
Business in Vancouver
May 30 - June 5, 2006

Profile: Carolyn Cross, CEO of Ondine Biopharma Corp.
Business in Vancouver
May 30 - June 5, 2006

Leading Edge BC will become part of government
Vancouver Sun
May 30, 2006

Stent remains key for Angiotech
Globe and Mail
May 26, 2006

Angiotech pays $40m for Quill Medical
Vancouver Sun
May 26, 2006

AstraZeneca buys top UK biotech firm for over £700m
Pilot Newsletter
May 26, 2006

Angiotech buys Quill for $40M
May 25, 2006
Globe and Mail

AOS joins forces with QLT to fight eye diseases
egoli News
May 21, 2006

AnorMed founder leaves top job
Vancouver Sun
May 25, 2006

AnorMed CEO quits suddenly as drug maker shifts direction
Globe and Mail
May 25, 2006

Let's tackle prescription-drug issues with complementary public policies
Globe and Mail
May 18, 2006

Boston Scientific wins approval in Europe for its Angiotech stents
Vancouver Sun
May 17, 2006

New-look Angiotech on the hook for debt repayments
Globe and Mail
May 17, 2006

Drugmaker offers 67% premium for biotech
Philadelphia Inquirer
May 16, 2006

Biotech firm raises furor with rice plan
Globe and Mail
May 15, 2006

Biotech deals could surpass $1.5-billion
Globe and Mail
May 15, 2006

Biotech booming, claims Ernst & Young report
FoodNavigator.com
May 12, 2006

B.C. pulls funds for high-tech marketers
Vancouver Sun
May 11, 2006

Gann rewarded for work with volunteer of year title
Times Colonist
May 10, 2006

Angiotech, Genzyme team up for research
Vancouver Sun
May 10, 2006

Lung cancer patients benefit from OncoGenex's lead drug Vancouver Sun
May 4, 2006

Canada Tops the World in Biotech Crop Research
USAgNet & Wisonsin Ag Connection
May 4, 2006